Could cheap water pills protect hearts in early kidney disease?
NCT ID NCT05171686
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study in 49 veterans with early chronic kidney disease (CKD) tested whether diuretics (water pills) can reduce fluid overload and improve heart health. Researchers measured changes in heart stress markers and symptoms like fatigue after 4 weeks of treatment. The goal was to lay groundwork for future studies on whether early use of these inexpensive drugs can prevent heart problems in CKD.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
diuretics (hydrochlorothiazide, chlorthalidone, furosemide, torsemide, bumetanide)
What this could lead to
If successful, this study could show that measuring fluid overload and treating it with diuretics early in kidney disease may improve heart health and symptoms.
What could go wrong
This is a small, early-phase study with only 49 participants, so results may not apply to everyone. It focuses on short-term changes, not long-term outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, 77030-4211, United States